Financhill
Back

Aurinia Pharmaceuticals 10K Form

Sell
38

AUPH
Aurinia Pharmaceuticals

Last Price:
5.01
Seasonality Move:
-4.52%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive AUPH News And Ratings

See the #1 stock for the next 7 days that we like better than AUPH

AUPH Financial Statistics

Sales & Book Value

Annual Sales: $175.51M
Cash Flow: $14.25M
Price / Cash Flow: 0
Annual Sales: $2.63
Price / Book: 1.92

Profitability

EPS (TTM): -0.53000
Net Income (TTM): $-78.02M
Gross Margin: $161.37M
Return on Equity: -19.92%
Return on Assets: -15.15%

Aurinia Pharmaceuticals Earnings Forecast

Key Aurinia Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 26 years for AUPH is 91.94%.
  • The Selling, General & Administrative Expenses for AUPH have been equal to 111.12% of Gross Profit Margin.
  • The Research & Development expenses have been 28.28% of Revenue.
  • The Interest Expense is -3.56% of Operating Income.
  • The Net Earning history of AUPH is -44.45% of Total Revenues.
  • Per Share Earnings over the last 26 years have been positive in 14 years.

Aurinia Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Healthcare
Current Symbol: AUPH
CUSIP: 05156V
Website: auriniapharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 5.5
Quick Ratio: 4.85

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 12.67

AUPH Technical Analysis vs Fundamental Analysis

Sell
38
Aurinia Pharmaceuticals (AUPH) is a Sell

Is Aurinia Pharmaceuticals a Buy or a Sell?